NovaBridge Biosciences (NBP) Income from Continuing Operations (2019 - 2025)
NovaBridge Biosciences (NBP) reported Income from Continuing Operations of 72858000.0 for Q4 2025, down 571.87% year-over-year from 15440143.68 in Q4 2024, and down 967.05% on a QoQ basis from 6828000.0 in Q3 2025.
NovaBridge Biosciences (NBP) has 5 years of Income from Continuing Operations data on file, last reported at 72858000.0 in Q4 2025.
- Quarterly Income from Continuing Operations fell 571.87% year-over-year to 72858000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 88340000.0 (down 77.76% YoY) and the FY2025 annual result came in at 88340000.0, down 77.76% from the prior year.
- Income from Continuing Operations declined to 72858000.0 in Q4 2025 per NBP's latest filing, from 6828000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 3150000.0 in Q1 2025 and bottomed at 72858000.0 in Q4 2025.
- The 3-year median for Income from Continuing Operations is 9419000.0 (2024), against an average of 19156818.18.
- The widest annual swing landed in 2024, when Income from Continuing Operations surged 70.62%; it then plunged 571.87% in 2025.
- Tracing NBP's Income from Continuing Operations over 3 years: stood at 36910000.0 in 2023, then surged by 70.62% to 10844000.0 in 2024, then sank by 571.87% to 72858000.0 in 2025.
- Per Business Quant, the three latest NBP Income from Continuing Operations figures stand at 72858000.0 (Q4 2025), 6828000.0 (Q3 2025), and 5504000.0 (Q2 2025).
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -72.86 Mn |
| Sep 30, 2025 | -6.83 Mn |
| Jun 30, 2025 | -5.50 Mn |
| Mar 31, 2025 | -3.15 Mn |
| Dec 31, 2024 | -10.84 Mn |
| Sep 30, 2024 | -20.49 Mn |
| Jun 30, 2024 | -8.94 Mn |
| Mar 31, 2024 | -9.42 Mn |
| Dec 31, 2023 | -36.91 Mn |
| Sep 30, 2023 | -8.22 Mn |
| Jun 30, 2023 | -27.56 Mn |
| Dec 31, 2020 | 160.85 Mn |
| Sep 30, 2020 | -82.36 Mn |
| Dec 31, 2019 | -49.46 Mn |
| Sep 30, 2019 | -35.10 Mn |